Julie Yoo's startup was founded on the discovery that despite patients waiting weeks for appointments, physician schedules were underutilized. This paradox of high demand and low utilization highlights a massive inefficiency in patient routing and capacity management, creating a significant market opportunity.
Unlike industries that digitized organically, healthcare's transition from paper was kickstarted by a massive federal program paying doctors to implement Electronic Health Records (EHRs). This forced, top-down digitization created the essential system-of-record infrastructure that modern health tech companies now build upon.
Current medical AI relies on electronic health records, which capture only infrequent snapshots of a person's health. The next breakthrough will come from companies that create new, continuous data rails by engaging with patients longitudinally, generating proprietary "N-of-one" datasets for superior models.
Unlike other sectors that invested heavily in workflow SaaS, healthcare's lack of investment means it has less technical debt. This allows a direct jump to AI-native systems, avoiding a costly "rip and replace" cycle and overcoming sunk-cost bias that plagues other industries.
The shift to high-deductible plans forced consumers to directly feel the financial burden of healthcare. This created a new willingness to pay out-of-pocket for disruptively priced, superior consumer health services, effectively establishing a viable direct-to-consumer (DTC) market that investors previously dismissed.
While LLMs can provide medical intelligence, they cannot perform physical tasks like drawing blood. The winning model uses AI for a disruptive cost structure internally while delivering a service with a real-world, regulated, or hardware-based moat that cannot be commoditized by a general AI.
